English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Background: a system L transporter L-type amino acid transporter 1 (LAT1) is upregulated to support  tumor cell growth in malignant tumor. Objective: The purpose of the present study was to investigate the  growth inhibition and [14C] L-leucine transport in human pancreatic adenocarcinoma cells MAIPaCa-2 and  BXPC3. Methodology: This animal study was carried out in Japan. The in vitro growth inhibition study  was performed by using KYT0351 and KYT0353 which inhibited the tumor cell growth in dose dependent  manner and uptake of [14C] L-leucine by MIAPaCa-2 and BXPC3 cells was Na+- independent and was  strongly inhibited by KYT0351 and KYT0353. The in vivo tumor growth inhibition was also carried out by  intra tumor injection of KYT0351 and KYT0353 at the concentration of 2.6mM of each on both the  MIAPaCa-2 and BXPC3 nude mice tumor. Result: In a subsequent survival study with the intra peritoneal  injection of ascites mice model, control mice had a mean life span of 20 ± 4.30 days and 21 ± 5 days in  MIAPaCa-2 and BXPC3 cells respectively, whereas the intraperitoneal injection of 10mg/kg twice daily of  KYT0351 and KYT0353 group had improved survival (mean life span 28.4 ± 8.5 and 34.4 ± 9.86 days, 26 ± 4.52 and 31.8 ± 7.62 days respectively in MIAPaCa-2 and BXPC3 cells). Kaplan-Meier survival data of  nude mice treated with KYT0351 and KYT0353 were significant. To study the mechanism of growth  inhibition we investigated the MIB-1 proliferation assay and TUNEL assay. Significantly less MIB-1  staining and more apoptotic nuclei was detected in tumors treated with KYT0351 and KYT0353 in both  MIAPaCa-2 and BXPC3 cells compared with saline treated group. Conclusion: In conclusion both the  KYT0351 and KYT0353 is a potent LAT1-specific inhibitor and LAT1 could be one of the molecular target  in pancreatic adenocarcinoma therapy. Journal of National Institute of Neurosciences Bangladesh,  2016;2(2): 55-68

Anti-Tumour Effects of High Affinity L-type Amino Acid Transporter1 Inhibitors on Human Pancreatic Adencarcinoma Cells